Are Finasteride-Related Penile Curvature/Peyronie’s Disease Adverse Event Reports Worthy of Further Clinical Investigation? Disproportionality Analysis Based on Both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) Pharmacovigilance Databases

May 2022 in “ International Journal of Impotence Research ”

Nicolò Schifano, Paolo Capogrosso, Luca Boeri, Giuseppe Fallara, Stefania Chiappini, Matthew Rewhorn, Omer Onur Cakir, Hannah Harvey, Fabio Castiglione, Hussain M. Alnajjar, Asif Muneer, Federico Deho', Fabrizio Schifano, Francesco Montorsi, Andrea Salonia

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on uhra.herts.ac.uk →

Discuss this study in the Community →

Cited in this study

11 / 11 results

research Post-Finasteride Syndrome: A Surmountable Challenge for Clinicians

30 citations , January 2020 in “Fertility and Sterility”

research Post-Finasteride Syndrome

11 citations , August 2019 in “BMJ”

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

research A Comment on the Post-Finasteride Syndrome

11 citations , November 2018 in “International Journal of Trichology”

research A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome

35 citations , October 2018 in “Urology”

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

research Androgenetic Alopecia: A Review

153 citations , March 2017 in “Endocrine”

Male pattern baldness involves genetics, hormones, and needs better treatments.

research Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia

14 citations , March 2017 in “Sexual Medicine”

Finasteride side effects in young men may be linked to specific gene variations.

1 / 1 results

research Are Finasteride-Related Penile Curvature/Peyronie’s Disease Adverse Event Reports Worthy of Further Clinical Investigation? Disproportionality Analysis Based on Both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) Pharmacovigilance Databases

2 citations , May 2022 in “International Journal of Impotence Research”

Are Finasteride-Related Penile Curvature/Peyronie’s Disease Adverse Event Reports Worthy of Further Clinical Investigation? Disproportionality Analysis Based on Both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) Pharmacovigilance Databases

We don't know much about this study yet.

Cited in this study

research Post-Finasteride Syndrome: A Surmountable Challenge for Clinicians

research Post-Finasteride Syndrome

research A Comment on the Post-Finasteride Syndrome

research A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome

research Androgenetic Alopecia: A Review

research Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia

research Post-Finasteride Syndrome: About 2 Cases and Review of the Literature

research Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride

research Hair Restoration Approaches for Early Onset Male Androgenetic Alopecia

research Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?

research Improvement in Androgenetic Alopecia in 53-76-Year-Old Men Using Oral Finasteride

Related

research Are Finasteride-Related Penile Curvature/Peyronie’s Disease Adverse Event Reports Worthy of Further Clinical Investigation? Disproportionality Analysis Based on Both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) Pharmacovigilance Databases